Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More
Xconomy
JUNE 10, 2016
Plans for new incubators were announced in two different cities. BIO president and CEO Jim Greenwood (pictured), a former Congressman-turned-lobbyist, told an audience, “We are fighting back,” and unveiled plans to put some of the blame for high drug prices on insurance companies.
Let's personalize your content